Blood samples from 15 ovarian cancer (OC) patients, 14 ovarian cancer patients with anti-Yo-associated paraneoplastic cerebellar degeneration (PCD), and 15 healthy controls were collected and miRNA analysis identified about 100 miRNAs with variable expression. This evidence concerns the gene CDR2 and ovarian cancer.